Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS

Go back to Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS
(NASDAQ: ALLO) Delayed: 2.01 +0.04 (2.03%)
Previous Close $1.97    52 Week High
Open $1.98    52 Week Low
Day High $2.03    P/E N/A 
Day Low $1.96    EPS
Volume 3,699,202